Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity

“Normal” for the gut microbiota For the benefit of future clinical studies, it is critical to establish what constitutes a “normal” gut microbiome, if it exists at all. Through fecal samples and questionnaires, Falony et al. and Zhernakova et al. targeted general populations in Belgium and the Netherlands, respectively. Gut microbiota composition correlated with a range of factors including diet, use of medication, red blood cell counts, fecal chromogranin A, and stool consistency. The data give some hints for possible biomarkers of normal gut communities. Science, this issue pp. 560 and 565 Two large-scale studies in Western Europe establish environment-diet-microbe-host interactions. Deep sequencing of the gut microbiomes of 1135 participants from a Dutch population-based cohort shows relations between the microbiome and 126 exogenous and intrinsic host factors, including 31 intrinsic factors, 12 diseases, 19 drug groups, 4 smoking categories, and 60 dietary factors. These factors collectively explain 18.7% of the variation seen in the interindividual distance of microbial composition. We could associate 110 factors to 125 species and observed that fecal chromogranin A (CgA), a protein secreted by enteroendocrine cells, was exclusively associated with 61 microbial species whose abundance collectively accounted for 53% of microbial composition. Low CgA concentrations were seen in individuals with a more diverse microbiome. These results are an important step toward a better understanding of environment-diet-microbe-host interactions.

[1]  J. Raes,et al.  Population-level analysis of gut microbiome variation , 2016, Science.

[2]  P. Bork,et al.  Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children , 2016, Nature Communications.

[3]  Jun Wang,et al.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota , 2015, Nature.

[4]  C. Huttenhower,et al.  The microbiome quality control project: baseline study design and future directions , 2015, Genome Biology.

[5]  D. Gevers,et al.  The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids , 2015, Circulation research.

[6]  Duy Tin Truong,et al.  MetaPhlAn2 for enhanced metagenomic taxonomic profiling , 2015, Nature Methods.

[7]  A. Zhernakova,et al.  Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics , 2015, BMJ Open.

[8]  C. Wijmenga,et al.  Cohort Profile Cohort Profile : LifeLines , a three-generation cohort study and biobank , 2015 .

[9]  K. Whelan,et al.  Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities , 2015, Gut.

[10]  G. Gibson,et al.  In vitro colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal microbiota growth , 2015, British Journal of Nutrition.

[11]  F. Greenway,et al.  Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels , 2015, Journal of diabetes science and technology.

[12]  P. Sroka,et al.  Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review , 2015, European Journal of Nutrition.

[13]  B. Rinner,et al.  Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers , 2015, Brain, Behavior, and Immunity.

[14]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[15]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[16]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[17]  Angela C. Poole,et al.  Human Genetics Shape the Gut Microbiome , 2014, Cell.

[18]  S. Hartmann,et al.  A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[20]  Susan P. Holmes,et al.  Waste Not , Want Not : Why Rarefying Microbiome Data is Inadmissible . October 1 , 2013 , 2013 .

[21]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.

[22]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[23]  David Weinkove,et al.  Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism , 2013, Cell.

[24]  M. Stridsberg,et al.  Increased Fecal Levels of Chromogranin A, Chromogranin B, and Secretoneurin in Collagenous Colitis , 2013, Inflammation.

[25]  Falk Hildebrand,et al.  Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice , 2013, Genome Biology.

[26]  R. Aslam,et al.  Chromogranin A-derived peptides are involved in innate immunity. , 2012, Current medicinal chemistry.

[27]  C. Huttenhower,et al.  Metagenomic microbial community profiling using unique clade-specific marker genes , 2012, Nature Methods.

[28]  F. Tinahones,et al.  Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. , 2012, The American journal of clinical nutrition.

[29]  Bernd W. Brandt,et al.  TaxMan: a server to trim rRNA reference databases and inspect taxonomic coverage , 2012, Nucleic Acids Res..

[30]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[31]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[32]  J. Clemente,et al.  The Impact of the Gut Microbiota on Human Health: An Integrative View , 2012, Cell.

[33]  L. Öhman,et al.  Altered Levels of Fecal Chromogranins and Secretogranins in IBS: Relevance for Pathophysiology and Symptoms? , 2012, The American Journal of Gastroenterology.

[34]  Rachael P. Huntley,et al.  The UniProt-GO Annotation database in 2011 , 2011, Nucleic Acids Res..

[35]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[36]  Y. Loh,et al.  The extended granin family: structure, function, and biomedical implications. , 2011, Endocrine reviews.

[37]  T. Hausken,et al.  Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome , 2010, Scandinavian journal of gastroenterology.

[38]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[39]  S. Lewis,et al.  Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers , 2010, Annals of clinical biochemistry.

[40]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[41]  R. Sidhu,et al.  Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? , 2010, Inflammatory bowel diseases.

[42]  M. Bardella,et al.  Plasma chromogranin a in patients with inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[43]  D. Foell,et al.  Elevated Human β-Defensin-2 Levels Indicate an Activation of the Innate Immune System in Patients With Irritable Bowel Syndrome , 2009, The American Journal of Gastroenterology.

[44]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[45]  B. Messing,et al.  Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. , 2008, Clinical nutrition.

[46]  Toshiaki Shimizu,et al.  Evaluation of psychosomatic stress in children by measuring salivary chromogranin A , 2006, Acta paediatrica.

[47]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[48]  A. Poullis,et al.  Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity. , 2003, European journal of gastroenterology & hepatology.

[49]  A. Røseth,et al.  High prevalence of NSAID enteropathy as shown by a simple faecal test , 1999, Gut.

[50]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[51]  J. Neoptolemos,et al.  Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients , 1987, The British journal of surgery.

[52]  P. Behl,et al.  Real time ultrasonography in the evaluation of hydrocephalus and associated abnormalities. , 1986, Indian pediatrics.

[53]  A. Macario,et al.  Isolation of Methanobrevibacter smithii from human feces , 1982, Applied and environmental microbiology.

[54]  H. G. Windmueller,et al.  Source and fate of circulating citrulline. , 1981, The American journal of physiology.